Perioperative diagnosis of cystosarcoma phyllodes of the breast may be enhanced by MIB-1 index

被引:18
作者
Ridgway, PF
Jacklin, RK
Ziprin, P
Harbin, L
Peck, DH
Darzi, AW
Rajan, PB
机构
[1] St Marys Hosp, Imperial Coll Fac Med, Dept Surg Oncol & Technol, London W2 1NY, England
[2] St Marys Hosp, Imperial Coll Fac Med, Dept Pathol, London W2 1NY, England
关键词
phyllodes; Ki-67; MIB-1; fibroadenoma; breast; diagnosis;
D O I
10.1016/j.jss.2004.07.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The recurring theme in cystosarcoma phyllodes (CSP) is one of underdiagnosis by pathologists and undertreatment by surgeons. Major areas of investigation relating to the diagnosis of CSP center on accurate preoperative diagnosis, elucidating the relevance of histological classification with respect to outcome, and identifying novel markers to reliably differentiate CSP from fibroadenoma (FA). Materials and methods. Fifteen CSP and 7 cellular FA controls (where the preoperative diagnosis was unclear) were retrospectively investigated. Preoperative histological and radiological investigations were reviewed for efficacy. The ability of MIB-1 antibody to differentiate the two fibroepithelial lesions was investigated using immunohistochemical estimation of the MIB-1 index. Results and discussion. Preoperative core biopsy had a sensitivity of 75% but was carried out in only 23% of cases. Fine needle aspiration cytology and radiological assessment were not efficacious in preoperative diagnosis. Proliferative activity (MIB-1 indices) was significantly higher in CSP than in a selected population of FA where there was preoperative diagnostic uncertainty (P < 0.0001). Indices were also able to determine CSP subclassification. This suggests MlB-1 as a constructive adjunctive investigation when evaluating histological features to differentiate CSP from FA in difficult cases. Conclusions. The use of MlB-1 may increase the sensitivity of preoperative core biopsy diagnosis, offering more effective surgical planning and decreasing immediate reoperation rates. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:83 / 88
页数:6
相关论文
共 50 条
  • [31] Comparison of quantitative and semiquantitative methods of assessing MIB-1 with the S-Phase fraction in breast carcinoma
    MacGrogan, G
    Jollet, I
    Huet, S
    Sierankowski, G
    Picot, V
    Bonichon, F
    Coindre, JM
    MODERN PATHOLOGY, 1997, 10 (08) : 769 - 776
  • [32] Classifying B-Cell Non-Hodgkin Lymphoma by Using MIB-1 Proliferative Index in Fine-Needle Aspirates
    Ali, Abdullah E.
    Morgen, Eric K.
    Geddie, William R.
    Boerner, Scott L.
    Massey, Christine
    Bailey, Denis J.
    Santos, Gilda da Cunha
    CANCER CYTOPATHOLOGY, 2010, 118 (03) : 166 - 172
  • [33] MIB1 labeling index as an indicator of chemoresponse in carcinoma of the breast
    Sharma, S
    Saboorian, MH
    Frawley, WH
    Frenkel, EP
    Haley, BB
    Ashfaq, R
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2004, 12 (04) : 290 - 295
  • [34] Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas
    Devaprasath, A
    Chacko, G
    NEUROLOGY INDIA, 2003, 51 (03) : 336 - 340
  • [35] Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression Clinical article
    Widhalm, Georg
    Wolfsberger, Stefan
    Preusser, Matthias
    Fischer, Ingeborg
    Woehrer, Adelheid
    Wunderer, Joerg
    Hainfellner, Johannes A.
    Knosp, Engelbert
    JOURNAL OF NEUROSURGERY, 2009, 111 (03) : 563 - 571
  • [36] Histopathology and MIB-1 labeling index predicted recurrence of meningiomas - A proposal of diagnostic criteria for patients with atypical meningioma
    Ho, DMT
    Hsu, CY
    Ting, LT
    Chiang, H
    CANCER, 2002, 94 (05) : 1538 - 1547
  • [37] CORRELATION BETWEEN THE BROMODEOXYURIDINE LABELING INDEX AND THE MIB-1 AND KI-67 PROLIFERATING CELL INDEXES IN CEREBRAL GLIOMAS
    ONDA, K
    DAVIS, RL
    SHIBUYA, M
    WILSON, CB
    HOSHINO, T
    CANCER, 1994, 74 (07) : 1921 - 1926
  • [38] Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System
    Maiseyeu, Ivan
    Gueresir, Agi
    Vatter, Hartmut
    Herrlinger, Ulrich
    Becker, Albert
    Wach, Johannes
    Gueresir, Erdem
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (23)
  • [39] MIB-1 labeling index correlated with magnetic resonance imaging detected tumor volume doubling time in pituitary adenoma
    Hsu, Chih-Yi
    Guo, Wan-Yuo
    Chien, Chen-Ping
    Ho, Donald Ming-Tak
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2010, 162 (06) : 1027 - 1033
  • [40] The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients
    Yoshida, Yuya
    Nakada, Mitsutoshi
    Harada, Tomoya
    Tanaka, Shingo
    Furuta, Takuya
    Hayashi, Yasuhiko
    Kita, Daisuke
    Uchiyama, Naoyuki
    Hayashi, Yutaka
    Hamada, Jun-ichiro
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 41 - 47